Suraksha Diagnostic Promoter Dr. Somnath Chatterjee Further Increases Stake with 7,800 Share Acquisition
Dr. Somnath Chatterjee, Promoter, Chairman, and Joint Managing Director of Suraksha Diagnostic Limited, has acquired 7,800 additional equity shares through the open market. This purchase increased his shareholding from 26,46,968 shares (5.082%) to 26,54,768 shares (5.097%), representing a 0.015% increase in ownership. The company has a paid-up capital of ₹10,41,61,516 with 5,20,80,758 equity shares of ₹2 face value each.
Suraksha Diagnostic Limited announced strong Q1 FY26 results with consolidated revenue rising 19.52% to ₹725.86 crore. EBITDA increased by 13.51% to ₹246.56 crore, and PAT grew 19.67% to ₹91.75 crore. The company launched Suraksha Genomics, acquired a 63% stake in Fetomat Wellness Private Limited, and added three new centers. Management expressed confidence in future growth, emphasizing expansion into genomic testing and AI-assisted diagnostics.
11Apr 25
Suraksha Diagnostic Expands Portfolio with Majority Stake Acquisition in Fetomat Wellness
Suraksha Diagnostic has acquired a 63.00% equity stake in Fetomat Wellness, making it a subsidiary. This strategic move expands Suraksha's portfolio in the healthcare sector, potentially diversifying its service offerings and strengthening its market position in diagnostic and wellness services.
09Apr 25
Suraksha Diagnostic Completes Acquisition of 63% Stake in Fetomat Wellness
Suraksha Diagnostic Limited has completed the acquisition of a 63% equity stake in Fetomat Wellness Private Limited for a total investment not exceeding ₹5.19 crore. This strategic move makes Fetomat Wellness a subsidiary of Suraksha, expanding its portfolio and operational reach in the healthcare sector. The acquisition aligns with Suraksha's previously announced plans and is expected to enhance its service offerings and technological capabilities in the wellness space.
28Mar 25
Suraksha Diagnostic Expands into Fetal Medicine with ₹51.9 Crore Investment in Fetomat
Suraksha Diagnostic Limited is investing ₹51.9 crore to acquire a 63% stake in Fetomat Wellness Private Limited, a network of fertility and pregnancy care clinics. The acquisition involves subscribing to new equity shares and purchasing existing shares. Fetomat specializes in fetal and maternal medicine, offering services like pregnancy care, prenatal diagnosis, and genetic counseling. This strategic move allows Suraksha to expand its service portfolio and strengthen its position in specialized medical services. The deal is expected to close within three months.
27Mar 25
Suraksha Diagnostic Expands into Fetal Medicine with Strategic Investment in Fetomat
Suraksha Diagnostic Limited has approved a strategic investment of up to ₹5.19 crore in Fetomat Wellness Private Limited, acquiring a 63% stake. The investment will be made through a combination of new equity shares subscription and purchase of existing shares. Fetomat specializes in fetal and maternal medicine, offering services like pregnancy care, prenatal diagnosis, and genetic counseling. This acquisition marks Suraksha's entry into specialized fetal and maternal medicine, expanding its service portfolio. Fetomat has shown significant growth since its incorporation in 2021, with its turnover increasing from ₹0.45 crore in FY 2021-22 to ₹4.11 crore in FY 2023-24.